These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

272 related items for PubMed ID: 19482729

  • 1. Urinary bone resorption markers (deoxypyridinoline and C-terminal telopeptide of type I collagen) in healthy persons, postmenopausal osteoporosis and patients with type I diabetes.
    Fassbender WJ, Gödde M, Brandenburg VM, Usadel KH, Stumpf UC.
    Adv Med Sci; 2009; 54(1):1-6. PubMed ID: 19482729
    [Abstract] [Full Text] [Related]

  • 2. Markers of bone resorption predict hip fracture in elderly women: the EPIDOS Prospective Study.
    Garnero P, Hausherr E, Chapuy MC, Marcelli C, Grandjean H, Muller C, Cormier C, Bréart G, Meunier PJ, Delmas PD.
    J Bone Miner Res; 1996 Oct; 11(10):1531-8. PubMed ID: 8889854
    [Abstract] [Full Text] [Related]

  • 3. A comparison of methods for measuring serum and urinary markers of bone metabolism in cats.
    DeLaurier A, Jackson B, Pfeiffer D, Ingham K, Horton MA, Price JS.
    Res Vet Sci; 2004 Aug; 77(1):29-39. PubMed ID: 15120950
    [Abstract] [Full Text] [Related]

  • 4. Markers of bone resorption--measurement in serum, plasma or urine?
    Huber F, Traber L, Roth HJ, Heckel V, Schmidt-Gayk H.
    Clin Lab; 2003 Aug; 49(5-6):203-7. PubMed ID: 15285175
    [Abstract] [Full Text] [Related]

  • 5. Urinary gamma-glutamyltransferase (GGT) as a potential marker of bone resorption.
    Asaba Y, Hiramatsu K, Matsui Y, Harada A, Nimura Y, Katagiri N, Kobayashi T, Takewaka T, Ito M, Niida S, Ikeda K.
    Bone; 2006 Dec; 39(6):1276-82. PubMed ID: 16942925
    [Abstract] [Full Text] [Related]

  • 6. Significance of serum CrossLaps as a predictor of changes in bone mineral density during estrogen replacement therapy; comparison with serum carboxyterminal telopeptide of type I collagen and urinary deoxypyridinoline.
    Okabe R, Inaba M, Nakatsuka K, Miki T, Naka H, Moriguchi A, Nishizawa Y.
    J Bone Miner Metab; 2004 Dec; 22(2):127-31. PubMed ID: 14999523
    [Abstract] [Full Text] [Related]

  • 7. Novel serum markers of bone resorption: clinical assessment and comparison with established urinary indices.
    Woitge HW, Pecherstorfer M, Li Y, Keck AV, Horn E, Ziegler R, Seibel MJ.
    J Bone Miner Res; 1999 May; 14(5):792-801. PubMed ID: 10320528
    [Abstract] [Full Text] [Related]

  • 8. Non-isomerized C-telopeptide fragments are highly sensitive markers for monitoring disease activity and treatment efficacy in Paget's disease of bone.
    Alexandersen P, Peris P, Guañabens N, Byrjalsen I, Alvarez L, Solberg H, Cloos PA.
    J Bone Miner Res; 2005 Apr; 20(4):588-95. PubMed ID: 15765177
    [Abstract] [Full Text] [Related]

  • 9. Body mass index (BMI) and parameters of bone formation and resorption in postmenopausal women.
    Papakitsou EF, Margioris AN, Dretakis KE, Trovas G, Zoras U, Lyritis G, Dretakis EK, Stergiopoulos K.
    Maturitas; 2004 Mar 15; 47(3):185-93. PubMed ID: 15036488
    [Abstract] [Full Text] [Related]

  • 10. Direct, enzyme-linked immunoassay for urinary deoxypyridinoline as a specific marker for measuring bone resorption.
    Robins SP, Woitge H, Hesley R, Ju J, Seyedin S, Seibel MJ.
    J Bone Miner Res; 1994 Oct 15; 9(10):1643-9. PubMed ID: 7817812
    [Abstract] [Full Text] [Related]

  • 11. Effects of age, menopause and osteoporosis on free, peptide-bound and total pyridinium crosslink excretion.
    Del Campo MT, González-Casaus ML, Aguado P, Bernad M, Carrera F, Martínez ME.
    Osteoporos Int; 1999 Oct 15; 9(5):449-54. PubMed ID: 10550465
    [Abstract] [Full Text] [Related]

  • 12. Urinary markers of altered collagen metabolism in fibromyalgia patients.
    Ribel-Madsen S, Christgau S, Gronemann ST, Bartels EM, Danneskiold-Samsøe B, Bliddal H.
    Scand J Rheumatol; 2007 Oct 15; 36(6):470-7. PubMed ID: 18092271
    [Abstract] [Full Text] [Related]

  • 13. Urinary hydroxypyridinium crosslinks of collagen as markers of bone resorption and estrogen efficacy in postmenopausal osteoporosis.
    Seibel MJ, Cosman F, Shen V, Gordon S, Dempster DW, Ratcliffe A, Lindsay R.
    J Bone Miner Res; 1993 Jul 15; 8(7):881-9. PubMed ID: 8352070
    [Abstract] [Full Text] [Related]

  • 14. Correlations of serum prolidase activity between bone turnover markers and mineral density in postmenopausal osteoporosis.
    Verit FF, Geyikli I, Yazgan P, Celik A.
    Arch Gynecol Obstet; 2006 Jun 15; 274(3):133-7. PubMed ID: 16532321
    [Abstract] [Full Text] [Related]

  • 15. Clinical usefulness of measurements of urinary deoxypyridinoline (DPD) in patients with postmenopausal osteoporosis receiving intermittent cyclical etidronate: advantage of free form of DPD over total DPD in predicting treatment efficacy.
    Kitatani K, Nakatsuka K, Naka H, Miki T, Morii H, Nishizawa Y.
    J Bone Miner Metab; 2003 Jun 15; 21(4):217-24. PubMed ID: 12811626
    [Abstract] [Full Text] [Related]

  • 16. Circulating levels of osteoclast activating cytokines, interleukin-11 and transforming growth factor-beta2, as valuable biomarkers for the assessment of bone turnover in postmenopausal osteoporosis.
    Shaarawy M, Zaki S, Sheiba M, El-Minawi AM.
    Clin Lab; 2003 Jun 15; 49(11-12):625-36. PubMed ID: 14651333
    [Abstract] [Full Text] [Related]

  • 17. Urinary cross-linked N-telopeptides of type I collagen and bone metabolic diseases.
    Xue Y, Jia W, Zhang H, Dong J, Clemens JD, Tian X.
    Chin Med J (Engl); 1999 Feb 15; 112(2):149-52. PubMed ID: 11593583
    [Abstract] [Full Text] [Related]

  • 18. Serum concentrations of interleukin 6, osteocalcin, intact parathyroid hormone, and markers of bone resorption in patients with rheumatoid arthritis.
    Al-Awadhi A, Olusi S, Al-Zaid N, Prabha K.
    J Rheumatol; 1999 Jun 15; 26(6):1250-6. PubMed ID: 10381038
    [Abstract] [Full Text] [Related]

  • 19. Prognostic value of urinary pyridinium crosslinks and their derivatives in multiple myeloma.
    Samani KK, Brazier M, Mathiot C, Kamel S, Jamart J, Jaubert J, Blanc M, Azaïs I, Facon T, Leleu X.
    Ann Hematol; 2005 Jan 15; 84(1):19-24. PubMed ID: 15338198
    [Abstract] [Full Text] [Related]

  • 20. Biochemical markers of bone turnover in percutaneous vertebroplasty for osteoporotic compression fracture.
    Komemushi A, Tanigawa N, Kariya S, Kojima H, Shomura Y, Tokuda T, Nomura M, Terada J, Kamata M, Sawada S.
    Cardiovasc Intervent Radiol; 2008 Jan 15; 31(2):332-5. PubMed ID: 18074174
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.